We are live on ! Find out more
LCM

Legato Capital Management Portfolio holdings

AUM $1.21B
1-Year Est. Return 82.36%
This Fund
S&P 500
This Quarter Est. Return
+3.68%
1 Year Est. Return
+82.36%
3 Year Est. Return
+243.02%
5 Year Est. Return
+342.37%
10 Year Est. Return
+764.01%
AUM
$709M
AUM Growth
+$176M
Cap. Flow
+$139M
Cap. Flow %
19.6%
Top 10 Hldgs %
18.66%
Holding
379
New
176
Increased
65
Reduced
23
Closed
11

Top Buys

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$12.8M
2
CVS icon
CVS Health
CVS
+$2.7M
3
SNEX icon
StoneX
SNEX
+$2.45M
4
JNJ icon
Johnson & Johnson
JNJ
+$2.33M
5
GS icon
Goldman Sachs
GS
+$2.3M

Sector Composition

Rank Sector Weight
1 Technology 12.71%
2 Healthcare 8.02%
3 Industrials 6.02%
4 Financials 5.03%
5 Consumer Discretionary 4.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LSTR icon
101
Landstar System
LSTR
$6.21B
$975K 0.14%
+6,171
New +$1.04M
AZUL
102
DELISTED
Azul
AZUL
$943K 0.13%
35,712
ABT icon
103
Abbott
ABT
$187B
$924K 0.13%
7,970
+2,129
+36% +$248K
CALY
104
Callaway Golf Company
CALY
$3.14B
$901K 0.13%
+26,714
New +$859K
GTLS
105
DELISTED
Chart Industries
GTLS
$854K 0.12%
+5,836
New +$856K
EXPE icon
106
Expedia Group
EXPE
$37.3B
$782K 0.11%
+4,776
New +$819K
IIPR icon
107
Innovative Industrial Properties
IIPR
$1.72B
$772K 0.11%
+4,044
New +$742K
WSC icon
108
WillScot Mobile Mini Holdings
WSC
$4.41B
$760K 0.11%
+27,265
New +$784K
FIVN icon
109
FIVE9
FIVN
$2.54B
$751K 0.11%
+4,095
New +$706K
TGTX icon
110
TG Therapeutics
TGTX
$7.62B
$751K 0.11%
+19,348
New +$760K
TFII icon
111
TFI International
TFII
$11.5B
$736K 0.1%
+8,074
New +$703K
WDC icon
112
Western Digital
WDC
$150B
$718K 0.1%
+13,340
New +$721K
RGEN icon
113
Repligen
RGEN
$9.25B
$708K 0.1%
+3,549
New +$688K
BBIO icon
114
BridgeBio Pharma
BBIO
$16.5B
$681K 0.1%
+11,171
New +$638K
BHVN
115
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$654K 0.09%
+6,740
New +$547K
ASTH icon
116
Astrana Health
ASTH
$1.77B
$651K 0.09%
+10,359
New +$383K
SMAR
117
DELISTED
Smartsheet Inc.
SMAR
$629K 0.09%
+8,698
New +$543K
ARCE
118
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
$620K 0.09%
20,208
EVBG
119
DELISTED
Everbridge, Inc. Common Stock
EVBG
$617K 0.09%
+4,536
New +$567K
AMRC icon
120
Ameresco
AMRC
$1.36B
$597K 0.08%
+9,519
New +$512K
SQSP
121
DELISTED
Squarespace, Inc.
SQSP
$583K 0.08%
+9,809
New +$559K
CHGG icon
122
Chegg
CHGG
$102M
$568K 0.08%
+6,829
New +$566K
TCBI icon
123
Texas Capital Bancshares
TCBI
$4.32B
$560K 0.08%
+8,825
New +$595K
MRTX
124
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$557K 0.08%
+3,448
New +$554K
JOYY
125
JOYY Inc
JOYY
$3.75B
$542K 0.08%
8,209
+2,811
+52% +$239K

Similar funds

Legato Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Legato Capital Management held 379 positions worth $709M, up 33% from $533M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Legato Capital Management deployed $139M of net new capital in Q2 2021, opening 176 new positions and adding to 65 existing holdings. Its largest new stake was iShares MSCI EAFE ETF: 160,511 shares worth $12.7M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Avid Bioservices, Inc. Common Stock, an estimated $272K trimmed.

  • Legato Capital Management's largest Q2 2021 buy was iShares MSCI EAFE ETF: 160,511 shares worth $12.7M.
  • Legato Capital Management added most to StoneX in Q2 2021, an estimated $2.45M increase.
  • Legato Capital Management's biggest Q2 2021 reduction was Avid Bioservices, Inc. Common Stock, cutting an estimated $272K.
  • Legato Capital Management fully exited Bryn Mawr Bank Corp in Q2 2021, selling an estimated $4.58M.
  • Legato Capital Management's ten largest holdings make up 19% of its $709M portfolio in Q2 2021.
  • Legato Capital Management opened 176 new positions and closed 11 in Q2 2021.
  • Legato Capital Management's portfolio value rose 33% quarter-over-quarter to $709M.

Based on Legato Capital Management's 13F filing for Q2 2021, filed 5 Aug 2021.